Community vs. Academic Care for CLL: What Dr. Cole Sterling Wants Patients to Know
- Most chronic lymphocytic leukemia (CLL) care happens in community oncology settings, where proximity, strong patient‑provider relationships, and easy access to routine monitoring make day‑to‑day management more seamless for patients.
- “By and large, CLL patients are managed in the community,” Dr. Sterling says, noting that many patients visit academic cancer centers mainly for second opinions or guidance on next steps in treatment.
- Academic centers offer specialized diagnostics, multidisciplinary expertise, and access to cutting‑edge clinical trials, and Dr. Sterling emphasizes that close communication between community and academic oncologists is essential to help patients receive care that aligns with their values and needs.
For patients with chronic lymphocytic leukemia patients (CLL), a leading expert breaks down the differences.
Read MoreAdvantages of receiving care at a community hospital can include:
- Proximity: Easy to access for appointments, especially if you live far from a major city.
- Personalized Care: Community oncology practices have been found to excel at fostering strong patient-provider relationships through a patient-centered approach that prioritizes empathy, communication, and accessibility.
- Ongoing Monitoring and Routine Care: For a chronic disease like CLL, community oncologists can manage routine blood work, symptom tracking, and standard oral or infused therapies close to home.
“But by and large, CLL patients are managed in the community,” he adds.
However, Dr. Sterling says “it’s critical” for community oncologists to stay up to date on treatment advances. He also notes the importance of having connections with academic specialists who can provide guidance and reassurance when needed.
Expert Resources for CLL Patients
- CLL is Not Considered Curable So Treatment May Resume Years Later
- CLL Treatment: The Side Effects to Expect & Why Reporting All New Symptoms is Crucial
- CLL Treatment Decision Making — Exploring All Your Options To Find What’s Right For You
- Active Surveillance For Chronic Lymphocytic Leukemia (CLL)
- After the Initial CLL Diagnosis: The First Conversation
Academic cancer centers typically see a higher volume of complex cases and often offer:
- Multidisciplinary Teams: Coordinated input from hematologists, transplant specialists, and researchers focused specifically on blood cancers.
- Specialized Diagnostics and Advanced Therapies: Academic centers such as Johns Hopkins often provide in-house molecular and genomic testing (e.g., FISH testing and IGHV mutation analysis used to risk-stratify CLL), along with access to stem cell transplantation and cellular therapy programs.
- Cutting-Edge Research and Clinical Trials: Academic centers may offer clinical trials of new drugs not yet widely available elsewhere. Most cancer clinical trials take place at academic medical centers rather than in community practices.
Despite these strengths, traveling to a major center can be stressful, time-consuming, and financially challenging for some patients — especially if it involves long distances or time away from work and family. Thankfully, there are ways to combine the convenience of local care with the benefits of advanced, specialized treatment.
Ultimately, Dr. Sterling says CLL care depends on honoring the patient’s values, maintaining close communication, offering encouragement, and reaching out early and often if there are questions or concerns about what’s next.
Learn more about SurvivorNet's rigorous medical review process.
